HomeInsights52 Week Low Stocks

Marksans Pharma Ltd 52 Week Low

Marksans Pharma Ltd 52 Week Low

stocks purchased

₹ 2.6 Cr

Volume transacted

stocks purchased

90.6 K

stocks traded

Last Updated time: 05 Nov 14:09 PM

Image

Marksans Pharma Ltd

NSE: MARKSANS

YEARLOW

112.45

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week Low of Marksans Pharma Ltd is ₹ 112.45 as of 04 Nov 24.

Company Fundamentals for Marksans Pharma Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 2024287.15
01 Nov 2024291.6
31 Oct 2024289.5
30 Oct 2024278.6
29 Oct 2024273.05
28 Oct 2024274.1
25 Oct 2024263.65
24 Oct 2024271.15
23 Oct 2024270
22 Oct 2024265.65

Asset Value vs Market Value of Marksans Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Marksans Pharma Ltd

No data available

* All values are in crore

Marksans Pharma Ltd News Hub

News

Marksans Pharma to declare Quarterly Result

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 12 Novembe...

Read more

23 Oct 202417:41

News

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

21 Aug 202420:00

News

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...

Read more

20 Aug 202414:37

News

Marksans Pharma to convene AGM

Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

20 Aug 202410:46

News

Marksans Pharma gets EIR from USFDA for Goa facility

The inspection has been classified as voluntary action indicated (VAI) and has been closed...

Read more

20 Aug 202414:48

News

Marksans Pharma surges after Q1 PAT rises 29% YoY to Rs 89 cr

Revenue from operations jumped 18.12% YoY to Rs 590.62 crore in first quarter of FY25, dri...

Read more

14 Aug 202412:04

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Marksans Pharma Ltd

Why is it important to track the 52-week low of Marksans Pharma Ltd stocks?

Investors should monitor the 52-week low of Marksans Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Marksans Pharma Ltd stocks hitting a 52-week low?

Factors leading to Marksans Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Marksans Pharma Ltd stocks when they hit a 52-week low?

Buying Marksans Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Marksans Pharma Ltd stocks?

Investors should monitor the 52-week low of Marksans Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Marksans Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Marksans Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Marksans Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Marksans Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Marksans Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*